Avacta Share Discussion Threads

[cf456] 22/2/2019 16:29

Quite a flurry of volume into the close.

[bumpa33] 22/2/2019 15:17

Some punters moving on as the story goes quiet for a while, however I think there are now a lot of folk watching this. I’m hoping for a dip back into the 30’s, I suspect many others are too though, so any opportunity may be short lived.

[cf456] 22/2/2019 14:40

Story still the same but pullback offering a top-up opportunity or a chance for new investors to get in at a lower price.

finnCap raised their target this month to 125p. That's 3x the current share price.

CEO at the latest update: "I look forward to updating the market on progress during 2019 which I expect to be a year of very significant progress for the Company."

Multiple licence deals are expected in the coming months. And of course they can land at any time.

[cf456] 22/2/2019 14:30

Looks to be seeing some buying interest around this level.

[1i1i1i] 20/2/2019 10:55

Avacta Affimer Innovative Immunotherapies Presentation February 2019

[blackbear] 15/2/2019 12:04

Thanks Nobby

[danatkins] 15/2/2019 10:05

All good. Hey there will be selling on the way which can emotionally affect each person differently. I held from the highs to the lows and bought more. in fairness MM where short of stock and selling has not really materialised so stock may still be low and ready for a nice up. Very over bought but holding up stronge is what I see

[patientcapital] 15/2/2019 08:58

Nobby, thank you. All quite upbeat subject to the usual.

[bumpa33] 15/2/2019 08:31

now AstraZeneca would be something....

obviously!

[bumpa33] 15/2/2019 08:30

thanks for the summary Nobby :)

[pugugly] 15/2/2019 08:14

Nobby Many thanks for sharing with US - U have a good day - R.

[lantanatony] 14/2/2019 20:53

Danatkins
Perhaps you are right .
It was only a question!
Trouble is with this blog is ,valid questions sometimes get silly reactions,mostly from amateur Rampers!
Like ii for example
A blogger that consistently insists that the M M's are short of stock.

[patientcapital] 14/2/2019 18:07

Thanks. Looking forward to your write up.

[nobbygnome] 14/2/2019 17:49

Very interesting presentations today, plus I had some good one to one discussions with the management and speakers. Will write up a summary later. The bottom line is that the were strong hints more deals are coming in the short term so I won't be selling!

Nobby

[toffeeman] 14/2/2019 17:47

Shame - lower low today.

[pugugly] 14/2/2019 16:55

Simple answer re sales - If you bought at 25p in placing and sell today placees have made 75% in 6 months and possibly want to lock in some profit.
All pharma is highly risky - Just look at MTFB today - Down to below 5p at market open and closed at 10.8p for a loss of 73% on yeserdays closing price. But if bought as a day trade gamble could have made 100% or reduced loss %age on existing holding - QED.

[1i1i1i] 14/2/2019 16:22

Ignore lantanatony, the levels of stupid questions he asks are off the scale, I seriously think he lives in a nut house!

[danatkins] 14/2/2019 16:20

It is what it is Tony. Stock moved 100% from the lows. Can't blame anyone taking a profit. I'm in to the end

[lantanatony] 14/2/2019 13:17

Why have these sellers appeared today!?
I just don't get it.
We're they spooked by rumours of a break up?!

[the drewster] 14/2/2019 07:37

I hope those attending today get an insight to the potential of the novel cancer therapeutics from the tufts collaboration, any insight to timelines for animal or human trials will be very interesting. I suspect this area in particular is being very closely scrutinised by MUCH larger organisations. If successful, it's hard to work out just how much little old Avacta might be worth, but has to be in the billions, surely?

Many cancer treatments are challenged when the rogue cells manage to avoid detection, so how very exciting to have the potential to make them show themselves so that they can be targeted by a chosen therapeutic and indeed the patient's own defences...

[toffeeman] 13/2/2019 17:53

As long as the higher lows persist :)

[hampton58] 13/2/2019 14:51

This scenario has been discussed before among investment managers.Would off course mean a complete re valuation of the company.Right now the most important driver is license deals and subsequent fee income .Exciting times ahead - but the Majors are active in this area and the stock have a major re valuation in the pipe line

[bumpa33] 13/2/2019 11:25

Interesting - that’s the first time I recall mention being made of potentially spinning off the re-agent división of the business into a separate entity?